Literature DB >> 8637180

Neuropeptide-Y-ATP interactions at the vascular sympathetic neuroeffector junction.

T C Westfall1, C L Yang, M Curfman-Falvey.   

Abstract

Neuropeptide Y (NPY) and ATP are considered cotransmitters with norepinephrine (NE) in sympathetic neurons innervating some blood vessels, including those of the mesentery. A prominent action of NPY is to potentiate the postjunctional contractile effect of NE as well as that of other vasoactive agents. We wished to investigate whether NPY also potentiates the contractile effect of ATP and, if so, to determine which receptor subtype mediates such an effect. The effect of NPY, the NPY-Y1-selective agent Leu31Pro34 NPY, and the NPY-Y2-selective fragment NPY 14-36 on the increase in perfusion pressure produced by ATP was examined in rat perfused mesenteric arterial bed. Results demonstrated that both NPY and Leu31Pro34 NPY but not NPY 14-36 potentiated the increase in perfusion pressure produced by ATP. These results suggest that NPY acts on Y1 receptors to enhance the postjunctional response of ATP. The putative NPY antagonist PYX2, but not the putative antagonists benextramine or PYX1, attenuated the effect of NPY, indicating that PYX2 acts as an NPY antagonist in this system. A major action of NPY is to enhance the postjunctional response of both cotransmitters, ATP and NE at the vascular sympathetic neuroeffector junction in the mesenteric arterial bed, and this may be mediated by NPY-Y1 receptors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8637180     DOI: 10.1097/00005344-199511000-00002

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  3 in total

1.  Purinergic and adrenergic Ca2+ transients during neurogenic contractions of rat mesenteric small arteries.

Authors:  Christine Lamont; Enrikas Vainorius; W Gil Wier
Journal:  J Physiol       Date:  2003-05-09       Impact factor: 5.182

2.  Adenosine 5'-triphosphate and neuropeptide Y are co-transmitters in conjunction with noradrenaline in the human saphenous vein.

Authors:  H Racchi; M J Irarrázabal; M Howard; S Morán; R Zalaquett; J P Huidobro-Toro
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

Review 3.  Stress, NPY and vascular remodeling: Implications for stress-related diseases.

Authors:  Lydia E Kuo; Ken Abe; Zofia Zukowska
Journal:  Peptides       Date:  2007-01-22       Impact factor: 3.750

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.